Elvitegravir

Back to search

Molecule Structure

Scientific Name

Elvitegravir

Description of the Drug

Elvitegravir is an antiretroviral agent used in combination with other antiretrovirals for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB09101

Brand Name(s)

Vitekta

Company Owner(s)

Gilead Sciences Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Human immunodeficiency virus type 1 integrase SINGLE PROTEIN INHIBITOR CHEMBL3471

Unichem Links

SureChEMBL SCHEMBL726252
DrugBank DB09101
PubChem: Thomson Pharma 16816905
PubChem 5277135
LINCS LSM-5647
Nikkaji J2.543.801I
PDBe ELV
BindingDB 50183273
DrugCentral 4300
ChemicalBook CB02464875
GSRS f1b48dfd-6b26-4910-9995-dbb1827d8b85
rxnorm ELVITEGRAVIR
PubChem: Drugs of the Future 12015964
ChEBI 72289
ZINC ZINC000013682481